CARIPRAZINE (has an active metabolite) | CARIPRAZINE | ATC N05AX15
NERVOUS SYSTEM ANTIPSYCHOTIC TREATMENT OF SCHIZOPHRENIA PARTIAL AGONIST DOPAMINE D2 RECEPTOR (KI = 0.49 NANOMOLAR) PARTIAL AGONIST SEROTONIN 5-HT1A RECEPTOR (KI = 2.6 NANOMOLAR) ANTAGONIST 5-HT2A RECEPTOR (KI = 18.8 NANOMOLAR) HISTAMINE H1 RECEPTOR (KI = 23.2 NANOMOLAR) | ORAL | Cmax 20 NANOMOLAR Tmax 4.5 HOUR PPB 94 PERCENT HT 72 HOUR | DOPAMINE D2 RECEPTOR 5-HT1A RECEPTOR | GPCR 5HT2A_HUMAN ANTAGONIST P28223 DRD2_HUMAN PARTIAL AGONIST P14416 5HT1A_HUMAN PARTIAL AGONIST P08908 | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |